Clinical Trial

Oral Metformin for Treating Melasma in Latin American Women

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated February 25, 2025 (before its estimated May 22, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to learn if metformin can treat melasma in Latin American women. The main question it aims to answer is: \- Can metformin help reduce the dark patches of melasma? Researchers will test two different doses of metformin (500 mg and 1000 mg) to see if either one helps improve melasma. Participants will: * Take a metformin pill every day for three months. * Go to the clinic twice: once at the beginning and once at the end of the study. * Get a phone call from the researchers to check how they're doing and ask about any changes or side effects.
Trial Details
NCT Number NCT06845540
Lead Sponsor University of Puerto Rico
Conditions Melasma
Enrollment 30 participants
Start Date 2025-02-20
Primary Completion 2025-05-22 (estimated)
Study Completion 2025-05-30 (estimated)
Updated on ClinicalTrials.gov 2025-02-25